Joincare Pharmaceutical Group Industry Co., Ltd. (600380.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 9.20

From 52W high−30.69%

Volume10.94M

Market capCNY 17.11B

P/E (TTM)12.8x

P/S (TTM)1.1x

Div yield2.39%

Key dataSep 18, 2026

Open

CNY 9.20

From 52W high

−30.69%

Volume

10.94M

Market cap

CNY 17.11B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.8x

P/E (TTM)

12.8x

RSI (14)

39.4

MomentumView details →

1D Return

−5.36%

YTD Return

−20.43%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

12.8x

EV/EBITDA

3.8x

EV/Sales

1.1x

P/S (TTM)

1.1x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

62.78%

Net Margin

8.85%

EBITDA Margin

29.23%

ROE (TTM)

8.42%

ROA (TTM)

3.71%

Asset Turnover

0.42x

GrowthView details →

Revenue YoY

−3.39%

EPS YoY

−1.84%

FCF YoY

+26.95%

Revenue CAGR 3Y

−3.90%

EPS CAGR 3Y

−2.74%

EBITDA YoY

—

MomentumView details →

1D Return

−5.36%

YTD Return

−20.43%

1Y Return

−27.52%

RSI (14)

39.4

vs 50D SMA

−6.79%

vs 200D SMA

−14.80%

Capital & dividendView details →

Debt/Equity

0.24x

Current Ratio

2.37x

Quick Ratio

2.14x

Div Yield

2.39%

Div Rate

CNY 0.22

Div Growth 1Y

+10.00%

EarningsView details →

EPS (Actual)

CNY 0.13

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−1.08%

Financials snapshotView financials →

Revenue (TTM)

14.85B

Net Income (TTM)

1.31B

Op. CF (TTM)

4.00B

Next earningsOct 22, 2026 →

Latest newsMore news →

Zhu Baoguo resigned as chairman, director and legal representative of Joincare Pharmaceutical Group for retirement reasons, effective upon delivery of his resignation, and Lin Nanqi was elected chairman of the ninth board.8d ago

Health Yuan announced it will provide an additional 40 million yuan entrusted loan to its controlled subsidiary Jiaozuo Jianfeng, with a five-year term and interest rate based on the one-year LPR, while also adjusting the interest rate on existing entrusted loans to the one-year LPR.55d ago

Similar companies

Grand Pharmaceutical Group Limited00512.HK 华润双鹤600062.SH Livzon Pharmaceutical Group Inc.01513.HK 步长制药603858.SH HUTCHMED (China) Limited00013.HK Fujian Haixi Pharmaceuticals Co., Ltd.02637.HK Find similar companies →

Latest newsMore news →

Zhu Baoguo resigned as chairman, director and legal representative of Joincare Pharmaceutical Group for retirement reasons, effective upon delivery of his resignation, and Lin Nanqi was elected chairman of the ninth board.8d ago Health Yuan announced it will provide an additional 40 million yuan entrusted loan to its controlled subsidiary Jiaozuo Jianfeng, with a five-year term and interest rate based on the one-year LPR, while also adjusting the interest rate on existing entrusted loans to the one-year LPR.55d ago